Talk:Gnaiger 2019 MitoFit Preprints: Difference between revisions

From Bioblast
No edit summary
 
(165 intermediate revisions by 3 users not shown)
Line 1: Line 1:
[[Image:BB-Bioblast.jpg|left|40px|link=http://www.bioblast.at/index.php/Bioblast:About|Bioblast wiki]]
__TOC__
__TOC__


'''» [[MitoEAGLE preprint 2018-02-08]]'''
== Nature Metabolism: NATMETAB-A19071509A Out to Review ==
== Phase 3: [[MitoEAGLE preprint 2018-02-08]] ==
:::: Dear Prof Gnaiger,
* 2018-02-15 [[Gnaiger E]] Version 24.  
:::: Thank you for submitting your manuscript "Mitochondrial respiratory states and rates" to Nature Metabolism. I am pleased to tell you that we are sending your paper out for formal peer review.
[[File:Mt-recovery.png|right|400px|thumb|Fig. 9. Mitochondrial recovery, ''Y<sub>mtE</sub>'', in preparation of isolated mitochondria.]]
:::: If you have not done so already, please alert us to any related manuscripts from your group that are under consideration or in press at other journals, or are being written up for submission to other journals (see www.nature.com/authors/policies/duplicate.html for details).
:::: Towards a shorter version: Old Fig. 9 was removed.  
:::: We are trying to improve the quality of methods and statistics reporting in our papers. To that end, we are asking all life sciences authors to complete two items: an editorial policy checklist that verifies compliance with all required editorial policies and a reporting summary that collects information on experimental design and reagents.
:::: Reporting summary: https://www.nature.com/documents/nr-reporting-summary.pdf
:::: Editorial policy checklist: https://www.nature.com/documents/nr-editorial-policy-checklist.pdf
:::: Please complete the relevant forms and return them within 48 hours. Please note that these forms are dynamic ‘smart pdfs’ and must therefore be downloaded and completed in Adobe Reader. We will then flatten them for ease of use by the reviewers. If you would like to reference the guidance text as you complete the template, please access these flattened versions at www.nature.com/authors/policies/availability.html
:::: All points on the policy checklist must be addressed; if needed, please send me a new version of the manuscript with your completed checklist.
:::: Finally, we would like to inform you that on a case by case basis we coordinate a brief consultation between referees and editors after all referee reports have been received. This is to improve the peer review process and the feedback provided to authors. Referees are given the opportunity to make comments on their peers’ concerns and update their reports to comment on issues raised by the other reviewers. If we feel it would be helpful, we will engage reviewers in this additional consultation with the goal of providing you with the most valuable feedback possible.
:::: We will be in touch again as soon as we have received comments from our referees. In the meantime - the status of your manuscript can be followed in the manuscript tracking system.  
:::: Best regards,
:::: Dr. Christoph Schmitt
:::: Chief Editor
:::: Nature Metabolism


* 2018-02-08 [[Gnaiger E]] Version 22. Change of title: '''Mitochondrial respiratory states and rates''': Building blocks of mitochondrial physiology. Part 1.
:::::: Dear co-authors and MitoEAGLE Network Members:


::::::* New manuscript version 22: www.mitoeagle.org/index.php/M
== Version 5 ==
::::::* Change of title: Mitochondrial respiratory states and rates
::::* 2019-07-24 [[Gnaiger 2019 MitoFit Preprint Arch]]
::::::* Section 3 removed
::::::* Your feedback will be appreciated until Feb 20


:::::: Our MitoEAGLE position statement originally entitled 'The protonmotive force and respiratory control' has been discussed in many meetings and working groups. Many opinions and concerns have been raised about: (''1'') the exploding length; (''2'') the heterogeneity from respiratory states, to protonmotive force, to normalization of respiratory flow and flux; (''3'') the complex thermodynamic treatment in Section 3 of compartmental systems, power and entropy production, exergy, forces, electric and chemical advancement, fluxes, molecular-molar-electrical formats, and motive units; and (''4'') corresponding concerns about the meaning of co-authorship, if an entire section of the manuscript remains a challenge rather than becoming a familiar piece of collaborative work for most participants.


:::::: In the attempt to give a more detailed introduction and provide clarification of some basic principles related to the protonmotive force, I tried to stick to the conventional presentations of electric potential differences, Δ''Ψ'', and chemical potential differences, Δ''μ''<sub>H+</sub>, up to the point of recognizing a physicochemical incompleteness in the formal representation of potential differences. I am highly motivated to share a very simple but fundamental solution of this generally unrecognized problem with you, and want to talk about this at EBEC2018. The physicochemical formalism of potential differences is incomplete and terminologically inconsistent. The protonmotive force is not an electrochemical potential difference, but a difference of 'stoichiometric potentials'. A generalized concept of 'isomorphic forces' is suggested to describe the incomplete although mathematically correct equation defining the protonmotive force more properly. Since this discussion appears to be presently beyond the scope of a MitoEAGLE position statement, '''Section 3 (The protonmotive force, proton flux, and respiratory control) was removed from the new Version 22, the manuscript was updated (see improved Figure 8; extended Table 5), and the title was changed to 'Mitochondrial respiratory states and rates''''.
== Version 5 for discussion ==


:::::: Many co-authors asked about the state of submission and possibilities to further contribute and improve our MitoEAGLE position statement. In this phase 3 towards journal submission, we are asking you and a wider range of experts in the field for '''input preferentially with corresponding references'''. This should allow us without too much further delay ('''deadline: Feb 20''') to incorporate your feedback and contact relevant journal editors for their opinion on implementing our recommendations into their journal policy. We want to proceed with submission to a preprint server and final journal submission. BBA was discussed at MiP2017 as a potentially suitable journal, and we are open for further suggestions.
[[File:MitoFit Preprint Arch pdf.png|left|160px|link=https://www.mitofit.org/index.php/File:Gnaiger_2019_MitoFit_Preprint_Arch_doi_10.26124_mitofit_190001.v5(in_prep).pdf |MitoFit pdf]]  <big><big>'''[https://www.mitofit.org/index.php/File:Gnaiger_2019_MitoFit_Preprint_Arch_doi_10.26124_mitofit_190001.v5(in_prep).pdf Mitochondrial respiratory states and rates]'''</big></big>
<br />
<br />
Version 5 ('''v5''') '''2019-07-12''' [[File:Gnaiger 2019 MitoFit Preprint Arch doi 10.26124 mitofit 190001.v5(in prep).pdf |''Version 5(3) in preparation'']]


:::::: With many thanks for your collaboration, Erich
Version 5 ('''v5''') '''2019-06-24''' [[File:Gnaiger 2019 MitoFit Preprint Arch doi 10.26124 mitofit 190001.v5(in prep).pdf |''Version 5(1) in preparation - changes are marked in the pdf for discussion.'']]


::: '''Relevant changes'''
:::: 2019-07-24 Updates according to feedback from [[Gonzalez-Franquesa A]] and Fig. 1 edited by [[Bravo RF]].
:::: 2019-07-12 [[Gnaiger E |Erich Gnaiger]]: A comment on 'Complex V' is added to Table 8:
:::::: Respiratory ET Complexes are redox proton pumps; Figure 2B; ATP synthase is not a redox proton pump of the ETS, hence the term Complex V should not be used
:::: 2019-06-24 [[Gnaiger E |Erich Gnaiger]]
:::::'''1.'''  ce: The term "Intact cells" has been replaced by "Living cells".
:::::: Rationale: see Table 5.
:::::'''2.''' "Extra-mitochondrial" has been changed to "Extramitochondrial".
:::::: Compare: extracellular.
:::::'''3.''' ""Excess ''E-P'' capacity has been changed to "ET-excess capacity, ''E-P''".
:::::: Rationale: ''E-P'' is the excess capacity of ''E'' over ''P'', but not excess over ''E-P''. 
:::::'''4.''' The symbol "pmf" for ''protonmotive force'' has be replaced by ''pmF''.
:::::: Rationale: (''1'') ''Italics'' are used for symbols of physicochemical quantities. (''2'') ''F'' but not ''f'' is the IUPAC symbol for ''force''.


* 2018-02-06 [[Gnaiger E]] '''[[MitoEAGLE preprint 2017-09-21 |Version 21]]''': Note: Subscript ‘§’ indicates throughout the text those parts, where ''potential differences'' provide a mathematically correct but physicochemically incomplete description and should be replaced by ''stoichiometric potential differences'' ([[Gnaiger 1993 Pure Appl Chem |Gnaiger 1993b]]). A unified concept on vectorial motive transformations and scalar chemical reactions will be derived elsewhere (Gnaiger, in prep.). Appreciation of the fundamental distinction between ''differences of potential'' versus ''differences of stoichiometric potential'' may be considered a key to critically evaluate the arguments presented in Section 3 on the protonmotive force. Since this discussion appears to be presently beyond the scope of a MitoEAGLE position statement, Section 3 will be removed from the [[MitoEAGLE preprint 2018-02-08 |next version]] and final manuscript. This section should become a topic of discussion within [[WG1 MitoEAGLE protocols, terminology, documentation |Working Group 1]] of the MitoEAGLE consortium, following a primary peer-reviewed publication of the concept of stoichiometric potential differences.
::: '''Added reference'''


== Further references ==
:::# Ling C, Rönn T (2019) Epigenetics in human obesity and type 2 diabetes. Cell Metab 29:1028-44. https://doi.org/10.1016/j.cmet.2019.03.009. - [[Ling 2019 Cell Metab |»Bioblast link«]]
::::* [[Bergeson_1981_West_J_Med]]
::::* [[Wheatley_2011_Metrologia]]


::: '''Coauthors''': Version 4: 542; present: 611




== Contacted editors ==
== ICJMD: Defining the role of authors and contributors ==
:: Updated 2018-02-12
::::* Biochem J
::::* Cell Metabolism
::::* Elsevier
:::::: Life Sciences
:::::: BBA Bioenergetics - Journal
:::::: Platelets
:::::: Pharmacological Research
:::::: Journal of Physiology and Biochemistry
::::* FEBS Journal
::::* FEBS Lett
::::* Int. J. Biol. Macromol.
::::* Journal of Experimental Biology
::::* J Physiol
::::* Mitochondrion: Keshav K. Singh
::::* PLOSOne


== Phase 3.1: Discussion ==
:::: "Some large multi-author groups designate authorship by a group name, with or without the names of individuals. When submitting a manuscript authored by a group, the corresponding author should specify the group name if one exists, and clearly identify the group members who can take credit and responsibility for the work as authors. The byline of the article identifies who is directly responsible for the manuscript, and MEDLINE lists as authors whichever names appear on the byline. If the byline includes a group name, MEDLINE will list the names of individual group members who are authors or who are collaborators, sometimes called non-author contributors, if there is a note associated with the byline clearly stating that the individual names are elsewhere in the paper and whether those names are authors or collaborators." - [http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html Downloaded from www.icmje.org 2019-01-04]


* 2018-02-17 [[Liu J]]
::::* Thank you very much for inviting me to be a coauthor of your masterpiece of mitochondrial history! I will try my best to be qualified for being a contributing co-author
::::: ''[[Gnaiger E]]'': I would be very thankful for receiving your comments and critical evaluation of the present version of our manuscript.


* 2018-02-16 [[Gnaiger E]]
== Comments ==
::::* Dear Anthony, Pushpa did a great job. Here is a first-level promising answer (see [http://www.mitoeagle.org/index.php/MitoEAGLE_preprint_2018-02-08#Answers here]]).
::::* At the beginning of page 7 (In Box1), it is mentioned the crosstalk between ER and mitochondria. I think it should be included that this interaction plays an important role also in lipid transport and biosynthesis. The second comment regards the mechanisms of respiratory uncoupling and in particular the acoupled respiration described in Fig 3, page 14 and table 2. The acoupled respiration is described as the respiration occurring in “non-compartmental mitochondrial fragments”. May be this concept could be explain further, since I think that acoupled respiration can refer to just fragments of the inner mitochondrial membrane but also mitoplasts (obtained by mitochondria swelling in hypotonic buffer). So, acoupled respiration could refer to cases in which the integrity of either only the outer membrane or both inner and outer membrane is compromised. ~ [[Fontanesi F]]
::::: ''[[Molina AJ]]'': That is fantastic!  I have worked with that editor before.  A positive response from her is a promising sign.
::::* I am happy to confirm that the pre-print has no flaws that I could see. It is truly an excellent work, for sure a manuscript of reference.  ~ [[Teodoro J]]
::::* I have been following the MitoEAGLE preprint on mitochondrial respiration, as well as the different comments. First of all, I am really interested in this topic, since as a student I already had troubles comparing different papers with different respiratory states, and this is a great opportunity to finally harmonize all the mitochondrial respiration experiments and publications. Pablo invited me to re-read it and make comments to contribute to the final final version. This would be a great honor, since this will be a reference paper in the future for experimental design and data reporting. .. I think it is a really elegant publication, with a lot of detail, but this is needed for the mitochondrial community to settle bases of nomenclature and harmonization. ~ [[Gonzalez-Franquesa A]]
::::* Finally, I took the time to read the “Mitochondria States and Rates” preprint during the flight back home, I have one small comment: at the bottom of page 14, below table I, I get a bit confused all the way in this paragraph, but mostly by the part starting as “Defined coupling states are induced by…” (4 lines from the bottom). Somehow the points 1-4 that follow seem to refer to the states described in Table 1 above. If so, it may be clearer to arrange these points in the same order: seems that uncoupling (point 4) should go before inhibition of phosphorylation pathways (point 3) – I hope I’m not wrong for this? More generally, it might be useful for less advanced reader to relate the different parts of this paragraph to the states described in table I, following the same order given in the table: LEAK, OXPHOS, ET, ROX. As it is this paragraph starts with OXPHOS, then ET, then LEAK, with point 3 in the final description apparently being ROX. ~ [[Joseph V]]
:::::: [[Gnaiger E]]: Many thanks for your positive feedback. Your suggestions for the MitoEAGLE white paper are very helpful. See the file (in prep for Version 5) for discussion: See pp. 14-15 for the re-arrangements. I hope that the confusion is now taken away – let me know.


* 2018-02-16 [[Kaambre T]
::::* Nevertheless [http://www.mitoeagle.org/images/3/30/MitoEAGLE_preprint_2018-02-08_%28Schlattner%29.docx below] some suggestions and remarks from my side, maybe you can use them for a revision. And of course I would be glad to see my favorite proteins mentioned (CK, NDPK, recent reviews attached). ~ [[Schlattner U]]
::::* I read the MitoEAGLE paper, and you've done a lot of work with it! It is more compact now, and it's much easier to read. The part of thermodynamics might be a separate article, this would be very important for young scientists and for the education in general in the field of bioenergetics.
::::* Please find ([http://www.mitoeagle.org/images/7/72/DMunro_-_Comments.docx attached]) my comments. I am glad to be part of this endeavour, which necessity is becoming increasingly clear every years! ~ [[Munro D]]
May be you could advise me? I have problem with terminology, but I´m not sure, is it the topic of our paper (Mitochondrial respiratory states and rates: Building blocks of mitochondrial physiology). It is not clear at all, when the mitochondrial preparations are in vivo, in situ, ex vivo or in vitro. With isolated mitochondria no problem, this mitochondrial preparation is always described as in vitro. But with mitochondria in cell cultures the terminology is very messy. I met various variants like in vivo, in situ and ex vivo in different papers. The story is not better also with permebilized samples and tissue homogenates.
::::* Fantastic initiative with the new mitochondrial physiology preprint server! ~ [[Donnelly C]]
::::: ''[[Gnaiger E]]'': Thank you for your positive feedback. I agree that the thermodynamics part is important. I was reluctant to remove it, but the arguments to reduce the complexity of the present MS were valid.
::::* It is quite surprising that the final manuscript was not accepted in BioRvix. I completely agree with MitoFit Preprints. ~ [[Singh BK]]
::::: You make a good point on the terminology of in vivo, in situ, ex vivo, .. I suggest that we ‘make it’ a topic of our paper, since we start with the definition of mitochondrial preparations. I suggest: all mitochondrial preparations are ‘in vitro’ (then we do not need ‘ex vivo’). In contrast to isolated mitochondrial and homogenate preparations, mitochondria can be considered as ‘in situ’ relative to the plasma membrane in permeabilized fibers and permeabilized cells. Do you think that everybody can agree on that? The text is included in the new version as a suggestion:
::::* It will be a pleasure to join the MitoEagle task group publication. ~ [[Laranjinha J]]
::::: “Mitochondrial preparations are defined as either isolated mitochondria, or tissue and cellular preparations in which the barrier function of the plasma membrane is disrupted. Since this entails the loss of cell viability, mitochondrial preparations are not studied in vivo. In contrast to isolated mitochondria and tissue homogenate preparations, mitochondria in permeabilized tissues and cells are in situ relative to the plasma membrane.” (I will upload the new version in a few minutes)
::::* I have a small remark : the concept of multiple authors signature started to be contested... By all ETHICS commities everywhere in Europa at least since it overpassed the usual rules... And also altered the signification of the authors impact factor. The regulation will be to form a consortium that is the true entity that will sign the collective work. That is teh best for teh COST since all members are easily identifiables. Overall conmment: This paper has been stanfding to long.... on teh bench! [[Petit PX]]
::::: Now we were invited by CELL METABOLISM to submit our manuscript for in-depth editorial evaluation.  
::::* I just found a minor typo. If you look at the “S” references, they are out of alphabetical order. ~ [[Sparagna GC]]
::::* Please find [http://wiki.oroboros.at/images/c/cd/Gnaiger_2019_MitoFit_Preprint_Arch_doi_10.26124_mitofit_190001_MCKENZIE.pdf attached] manuscript with comments (I have made 5 in total). Feel free to incorporate (or ignore) as you see fit! ~ [[McKenzie M]]
::::::* ''[[Gnaiger E]]'': To address your comment “Interesting that you state saturating O2, as this is only at the start of an experiment? (but is accounted for in the oxygraph calibration with dithionite, so that measured respiration rates are relative to saturating O2?).”, I extended Section 2.1.2: “Kinetically-saturated conditions are evaluated by substrate kinetics to obtain the maximum reaction velocity or maximum pathway flux, in contrast to solubility-saturated conditions.”
:::::: We are in direct contact with Kyle Hoehn to obtain and test their uncouplers.


* 2018-02-15 [[Gnaiger E]]
:::::: To summarize your comment “So would it be optimal in publications to not only state final flux rates/unit sample (e.g per mg) but also the raw flux rates (per mL) and the mg of sample used?”, I extended Box 3:Box 3: Recommendations for studies with mitochondrial preparations
::::* Dear Prof. Liu Shusen, I would be very thankful for receiving your comments and critical evaluation of the present version of our manuscript. Below is the link to our updated version.
:::::: ●  Normalization of respiratory rates should be provided as far as possible:
::::: ''[[Liu SS]]'': I will give my response as much as possible to you after my finishment of reading it. but, I am not sure every point I could agree with that noted in the manuscript, although, it is very good totally and generally! My main consideration is that biomembrane bioenergetics ,the study on mitochondrial oxidative phosphorylation is still in the rapid period of development and refinement, not only technically, but also theoritically/conceptionally. So, I need get time to learn and to read more recent scientific research achievements and progresses, including your manuscript!
::::::: A. Sample normalization
:::::::: 1. Object-specific biophysical normalization: on a per organism or per cell basis as O2 flow; this may not be possible when dealing with coenocytic organisms, e.g., filamentous fungi, or tissues without cross-walls separating individual cells, e.g., muscle fibers.
:::::::: 2.  Size-specific cellular normalization: per g protein; per organism-, cell- or tissue-mass as mass-specific O2 flux; per cell volume as cell volume-specific flux.
::::::::3.  Mitochondrial normalization: per mitochondrial marker as mt-specific flux.
::::::: B. Chamber normalization
:::::::: 1. Chamber volume-specific flux, JV [pmol∙s-1∙mL-1], is reported for quality control in relation to instrumental sensitivity and limit of detection of volume-specific flux.
:::::::: 2. Sample concentration in the instrumental chamber is reported as number concentration, mass concentration, or mitochondrial concentration; this is a component of the measuring conditions.
:::::: With information on cell size and the use of multiple normalizations, maximum potential information is available (Renner et al. 2003; Wagner et al. 2011; Gnaiger 2014). Reporting flow in a respiratory chamber [nmol∙s-1] is discouraged, since it restricts the analysis to intra-experimental comparison of relative (qualitative) differences.


* 2018-02-15 [[Sharma P]]
::::* I am happy to see that we are one step closer to the final publication of the MitoEAGLE manuscript in a journal. ~ [[Komlodi T]]
::::* I have received a response from "CELL METABOLISM".  Looks like they are interested in our manuscript. Please read their response and advise me what to do next.  
::::* It is a great step towards the publication of the manuscript and congratulations for creating your own tool to circumvent decisions that can not be easily understood. ~ [[Thierry A]]
::::: ''[[Gnaiger E]]'': Thank you so much for your correspondence with CELL METABOLISM. This sounds like the door is not closed. I propose that I will add the Executive summar into the present pdf file and send the whole manuscript to Nikla Emambokus, Editor-in-Chief, Cell Metabolism. In any case, it will be interesting to receive his response.
::::* Excellent article and one of its kind too. Please let me how can i help to get it published in a high impact j. Look forward to work in your team. ~ [[Sharma P]]
::::: [[Sharma P]]: Excellent idea to polish the manuscript and submit to CELL METABOLISM ASAP before editor changes his mind.
::::* It's great to see the preprint. The preprint server in the area of mitochondrial physiology is a great idea and definitely will be a success. ~ [[Tomar D]]
::::: ''[[Gnaiger E]]'': Dear Dr. Emambokus, we thank you for your interest in evaluating our manuscript ‘Mitochondrial respiratory states and rates: Building blocks of mitochondrial physiology’ in your in-house editorial review system.  
::::* First and foremost I would like to express my deepest gratitude and would like to thank you for giving us your time to review our manuscript and be part of us as the co-author. It is a great honour to get you in touch and reply promptly. .. I would like to also thank you for giving me the opportunity to be part of the MitoEAGLE as one of the co-authors and I am happy to be listed in the next version of the preprint. ~ [[Hassan H]]
::::: A pdf file of the full manuscript is attached. A Task Group of the COST Action MitoEAGLE has been working on this manuscript with Open Access as a ‘MitoEAGLE preprint’ and the ultimate aim of peer-reviewed publication: » http://www.mitoeagle.org/index.php/MitoEAGLE_preprint_2018-02-08
::::* However - just a note about pre-prints. A significant portion of scientists that I collaborate with feel uncomfortable submitting manuscript on a pre-print server. Is this something that could be addressed maybe in an article regarding the benefits and nuances of pre-print server submission. ~ [[Towheed A]]
::::: The global MitoEAGLE network made it possible to collaborate with more than 250 co-authors to reach consensus on the present manuscript. Nevertheless, we do not consider scientific progress to be supported by ‘declaration’ statements (other than on ethical or political issues). Our manuscript aims at providing arguments for further debate rather than pushing opinions.  We hope to initiate a much broader process of discussion and want to raise the awareness on the importance of a consistent terminology for the reporting of scientific data in the field of bioenergetics, mitochondrial physiology and pathology. Quality of research requires quality of communication. Some established researchers in the field may not want to re-consider the use of jargon which has become established despite deficiencies of accuracy and meaning. In the long run, superior standards will become accepted. We hope to contribute to this evolutionary process, with an emphasis on harmonization rather than standardization.
::::: The manuscript has not yet been formatted for a specific journal. We will be glad to ensure that-before submission-an updated version conforms to the format guidelines for your journal, should you encourage us to proceed with submission at your EM site.
::::: We are looking forward to hearing your opinion about the timeliness and potential impact of our manuscript, and possibly your suggestions for improvement.
::::: With many thanks for your consideration,
and kind regards, Erich Gnaiger
:::::* [[http://www.mitoeagle.org/index.php/MitoEAGLE_preprint_2018-02-08#Answers Estrompas answer to Dr. Gnaiger]]


* 2018-02-15 [[Watala C]]
:::* '''FAQ''' - [[Preprint|MitoPedia:Preprint]]
::::* I have sent the enlosed letter to several jpournals, in which we published during the last 5 years, and which may have something in common with mitochondrial physiology. I have included you as the “to your information” addressee.
::::: ''[[Gnaiger E]]'': Many thanks for your great efforts!


* 2018-02-14 [[Wagner BA]]
::: '''Journal submission comments'''
::::* Dr. Gnaiger, here are some suggestions or items that might need to be double checked. Most of the items are minor. The manuscript looks great
::::: Thank you for your effort.  This manuscript is timely, informative, and clearly sets forth the future: highly educational as well. No single author or smaller group could do what’s been accomplished here. Again, I must Thank you for orchestrating it so well!
::::: I found a couple of things in the manuscript where some items need to be double checked, clarified, or verified that they are not typos or missing characters as posted (Version 22_2018-02-08 ). Hopefully, the below listed comments will aid in the final manuscript and publication. and editing.
:::::: Lines 210-211:  might be better as “enzymes of the tricarboxylic acid and fatty acid oxidation”.
:::::: Lines 219-223:  Possible to many “and’s, not sure if this is a run on sentence or not.   
:::::: Line 404: (10 ug•10-6 cells) is this 10-6 cells or 106 cells, also is the dot the best way to separate the 2 different normalization values?
:::::: 464, 524-525, Figure 3 Note 5 and through the whole manuscript: “superoxide anion radical” could be simply “superoxide” unless the intent is to educate people unfamiliar with this molecule and highlight that it’s a radical and an anion.
:::::: Line 741:  is (CHNO; 2[H]) correct or a typo or missing a character?
::::: ''[[Gnaiger E]]'': Dear Brett, many thanks for your excellent comments and (already earlier) contributions. We have an interesting reply from CELL METABOLISM (see[[MitoEAGLE_preprint_2018-02-08#Answers| here]]). We will send them the MS.


::::* Cell Metabolism seems like a good first choice. ~ [[Williams C]]
::::* Cell Metabolism, I think this is a good choice. ~ [[Rossiter HB]]
::::* Cell Metabolism seems highly appropriate. ~ [[Newsom SA]]
::::* No preference. Just go ahead. ~ [[Zaugg M]]
::::* I concur with the choice of cell metabolism. ~ [[Pulinilkunnil T]]
::::* I think cell metabolism would be great, but I doubt whether it is realistic. Possibly Molecular Metabolism (very rapid, good reputation, european), Cell and Molecular Life Sciences (many reviews) or BBA- bioenergetics could be alternatives. ~ [[Keijer J]]
::::* Alternatives if Cell Met is not accepting: Nature metabolism or Acta physiologica. ~ [[Amati F]]
::::* And Cell met is a good 1st choice for this publication. ~ [[Zanou N]]
::::* The question is why did Biorxiv reject the manuscript? Before submitting to a prestigious journal like Cell Metabolism all the doubts Biorxiv had should be ruled out. ~ [[Methner A]]
::::* And I think that Cell Metabolism is a good first journal choice for submission of our manuscript. ~ [[Breton S]]
::::* Cell Metabolism is a good option as a first submission. ~ [[Bouitbir J]]
::::* Cell metabolism is a good fit for the manuscript. ~ [[Adiele RC]]
::::* The choice of journal is excellent, although it might be a long shot. ~ [[Oliveira MT]]
::::* I guess that also  TIBs  or Current Biology could be considered. ~ [[Calabria E]]
::::* I am in agreement that the first journal will be Cell Metabolism. ~ [[Victor VM]]
::::* Cell metabolism is an excellent choice. If they are interested that would be wonderfull. Physiological Reviews could be an alternative, in case Cell metabolism declines the manuscript. ~ [[Thierry A]]
::::* I would suggest to try the submission in Cell Metabolism. ~ [[Doerrier C]]
::::* Regarding the future submission of our paper, if there is already a pre-acceptance of the Editor of Cell Metabolism, I believe we should submit there. There are not many journals willing to publish a paper with so many authors, and the reviewing process will not be easy, in my opinion. ~ [[Crisostomo L]]
::::* I think cell metabolism is a good target to submit our article. ~ [[Salin K]]
::::* I would format accurately as a resource manuscript for Cell Metabolism. ~ [[Lavery GG]]
::::* The manuscript is still extremely long. In my modest opinion too long compared to the editorial format limits of many journals. If the manuscript cannot be substantially shortened to the essentials (in my opinion preferable) one strategy is to try to find a journal without such limits. ~ [[Spinazzi M]]
::::* I am happy with Cell Metabolism to start the submission process of this preprint. ~ [[Moisoi N]]


* 2018-02-13 [[Lemieux H]]
== 2019-07-22 Circular to coauthors ==
::::* Here are a few additinal comments on the review [http://wiki.oroboros.at/images/a/ae/MitoEAGLE_preprint_2018-02-08-HL_edit.pdf (pages 6, 13, 25)]. I'm still a little bit under the impression that it is very complex for general users to apply properly all the nomenclature. 
::::: About the editors, nobody comes into my mind but I will look if I can find some to send the letter of information too.


* 2018-02-13 [[Velika B]]
::: '''Re: MitoEAGLE preprint on ‘Mitochondrial respiratory states and rates’'''
::::* I think, the letter to the editor you sent is it's really nicely written, with all needed information.


* 2018-02-13 [[Victor VM]]
:::: Dear coauthors,
::::* Thank you very much for your collaboration adn invitation. I think that it is a very nice article.
::::: I will send it to the editors.
::::: In fact, this afternoon I have a meeting with Santiago Lamas who is an associate editor of redox Biology,and I can talk about the article.


* 2018-02-13 [[Villena JA]]
:::: The recent MiP/MitoEAGLE Training School in Coimbra provided another excellent opportunity to present the concept of our ‘States and rates’ white paper, to discuss it with several students and scientists who joined as additional coauthors, and to take a decision on journal submission.
::::: ''[[Gnaiger E]]'':May I ask you to send a letter with the information contained in the template (feel free to modify) to relevant editors whom you know.
::::* Thanks, Erich. I will do so.


* 2018-02-12 [[Battino M]]
:::: 1. Preprint version 5 (in prep) is now available for your evaluation before proceeding with journal submission. At this stage, the MitoFit Preprint version 5 (in prep) has not yet a DOI, to allow final changes to be made according to the immediate feedback received upon this circular. The latest changes are listed on the website, minor changes and improvements are included in the manuscript:  
::::* I deeply appreciate your efforts to make the text more affordable also for not-experts in the field: I agree with you and I am convinced that this help to better widespread the message inside and to gain much more visibility and an enhanced number of potential reader will be reached.
::::: BTW, I am preparing to send the letter you suggested to some EiC but I think it would be useful to avoid any overlapping in this task: therefore I am suggesting you make available a list of EiC/journals already contacted in order it could be easier to resend the same letter to the same EiC.
::::: Moreover, before sending the letter, the sender should advise you for a continuous update of the list.
::::: You can also prepare a doodle/surveymonkey or similar where each contributor could add by his/her own the journal contacted.


* 2018-02-12 [[Buettner GR]]
::::» www.mitofit.org/index.php/Talk:Gnaiger_2019_MitoFit_Preprint_Arch
::::* I offer some suggestions.
::::: ''[[Gnaiger E]]'': Many thanks for your excellent comments and (already earlier) contributions. We have an interesting reply from CELL METABOLISM (see [http://www.mitoeagle.org/index.php/MitoEAGLE_preprint_2018-02-08#Answers Dr.Sharma]). We will send them the MS.
::::: ''[[Buettner GR]]'': This manuscript has had a rigorous “internal” review.  Thus, a journal’s review would not be expected to add too much. 
::::: I think you are in the driver’s seat, as many journals would welcome this work. I would not bend too much to a specific journal’s demands.  Bargain hard if the editor(s) want changes in format, length etc. 
::::: To ensure the work gets into PubMed Central (12 mo from publication), I assume an author(s) must have NIH grant support.  I have such support.  Others may as well.  Thus, this may need consideration.  ::::: I have done this for other collaborative works; obviously it helps me justify my grant -- showing productively and progress, but most important it assists with long-term accessibility. 
::::: The goal is to get easy and wide distribution to all researchers whose research touches on this area. 
::::: ''[[Stocker R]]'': I completely agree with Garry. Accessibility is going to be a key determinator whether this project will be a success and result in broad adherence to the guidelines provided.


* 2018-02-12 [[Calabria E]]
:::: 2. Please finally check your personal page for any corrections to be made in your initials and affiliations.
::::* Dear Erich, thanks a lot. I think this is a great idea. I sent the message contained in the attachment to three editors I’ve been in contact with and their colleagues.


* 2018-02-12 [[Chen Q]]
:::: 3. Feel free to invite additional colleagues to evaluate our white paper and join as coauthors.
::::* I would suggest you to contact Prof. Liu Shusen for his comments. I copy this message to him so that he may be helpful.
::::: ''[[Gnaiger E]]'': Many thanks for reaching out to Prof. Liu Shusen. I have gladly added you to the list of co-authors of our MitoEAGLE Position Statement.
::::: We recieved an interesting reply from CELL METABOLISM (see preprints main page). We will send them the MS.


* 2018-02-12 Jadiya P
:::: 4. We have announced the plan for journal submission for quite some time, but the number of coauthors increased to 612 and many discussions lead to further improvement of the manuscript. Our first goal for submission has been ‘Cell Metabolism’. Since then, the new journal ‘Nature Metabolism’ was launched. Feedback from several coauthors, and the interest of the editor of ‘Nature Metabolism’ in our white paper, has led to a change in the strategy, to submit primarily to the European journal ‘Nature Metabolism’, since the COST Action MitoEAGLE is a European project-with worldwide participation.
::::* I have gone through the preprint version and its really nice compilation of our current understanding of the mitochondrial physiology as well as related terminology. In the Box1, Line 229, it would be great to add one sentence for the endoplasmic reticulum and mitochondrial contacts as these contact sites involved in metabolites transfer as well as mitochondrial dynamics regulation.  
::::: "The crosstalk between mitochondria and endoplasmic reticulum are involved in the regulation of various cellular functions, such as calcium homeostasis, cell division, autophagy, differentiation, anti-viral signaling, and others (Murley and Nunnari 2016)".
::::: Ref: Murley A, Nunnari J (2016) The Emerging Network of Mitochondria-Organelle Contacts. Mol Cell 61(5):648-653.
::::: ''[[Gnaiger E]]'': Many thanks for your contribution, which I added according to your suggestion (line 217). Thanks for joining our initiative as a co-author.


* 2018-02-12 [[Keijer J]]
:::: With many thanks for your contributions and for supporting the MitoEAGLE project,  
::::* I has become a balanced and high quality document. Nevertheless still some comments. Please find these [http://www.mitoeagle.org/images/b/b0/Comments_jaap_keijer_preprint_20180208.pdf attached] (written in the scan and I added only the pages with comments). Please find also an alternative [http://www.mitoeagle.org/index.php/File:Keijer_Abstract_suggestion.docx abstract], which is slightly altered (improved) over the one pasted in the scan.
::::: '[[Gnaiger E]]'': Thank you very much, your input is much appreciated and largely included in the new ms version. We have an interesting reply from CELL METABOLISM (see[[MitoEAGLE_preprint_2018-02-08#Answers| here]]). We will send them the MS.


* 2018-02-12 [[Spinazzi M]]
:::: Erich
::::* I believe there is strong need for such armonization procedure.
::::: A detail regarding it. I would personally propose to redefine the electron transfer capacity as ETC rather than ETS –it is less confusing.


* 2018-02-12 [[Trougakos IP]]
:::: Erich Gnaiger, Ph.D.
::::* Thank you for the email and the attached paper.
:::: Chair COST Action MitoEAGLE
::::: I found the paper really very informative and as discussed before the initiative is very much needed and timely.
:::: [email protected] | www.mitoeagle.org
::::: At this point I have no further input; we do have some papers in Revision and if we get them through I will send the citations for adding in this Review paper.


* 2018-02-12 [[Vyssokikh MY]]
::::* It's a pleasure to participate in such interesting project for me, thank You for invitation!


* 2018-02-10 [[Coen PM]]
== 2019-03-12 Circular to coauthors ==
::::* A suggestion is to post something similar to relevant sections at the American Physiological Society. (http://connect.the-aps.org/home). You could probably sent this to all sections, but I’m pretty sure there would be interest from members of the endocrinology and metabolism and exercise physiology sections.


* 2018-02-10 [[Tretter L]]
::: '''Re: MitoFit_Preprint_Archives'''
::::* I would send it to the editor in Chief of Mitochondrion. Is it OK?
::::: ''[[Gnaiger E]]'':Excellent – thanks


* 2018-02-09 [[Arnould T]]
:::: Dear coauthors,  
::::* the demand specifies to send the information to Editors of Journals that I know. I could do that for J. Cellular Physiology but do not you expect a higher and more poweful journal to publish this excellent paper ? In addition, the timing....would be bfore you submit or after...


* 2018-02-09 [[Dias T]]
:::: We thank you for the feedback received to our previous circular. Here is the summary of 176 answers to the three questions on preprints, which encourages us to proceed with '''MitoFit Preprint Archives''':
::::* I want to congratulate you and all the co-authors for the excellent work. The manuscript has highly improved since my last reading. I am sending some minor suggestions annotated in the [http://www.mitoeagle.org/images/2/25/MitoEAGLE_preprint_2018-02-08_TRD.pdf attached pdf file]. Thank you very much for the collaboration,
:::::[[MitoFit_Preprint_Archives#Preprint_questionnaire |Summary on preprint questionnaire]]
::::: ''[[Gnaiger E]]'': Thank you for your kind feedback and for the careful reading with excellent improvements – obviously you are a professional science writer. I have incorportated your suggestions in the new version 24.


* 2018-02-09 [[Keijer J]]
:::: The [[MitoFit_Preprint_Archives#Advisory_Board |Scientific Advisory Board]] has expanded, and we thank all MitoEAGLE members who have joined the International Board. Again we extend our invitation to join the editorial team. In particular, we would like to establish a '''Member Advisory Board''' including scientific organizations and journals which support the concept of '''MitoFit Preprints'''. If you are involved in such an organization, please let us know if joining the 'Member Advisory Board' might be an option for your organization.
::::* I think Cell Metabolism is hardly possible. Did you consider JBC (with John Demu as editor for mitochondria) or Nature Communications? Maybe also Molecular Metabolism, but that may be too little physiological.


* 2018-02-09 [[Koopman WJ]]
:::: Information on next steps for [[Gnaiger_2019_MitoFit_Preprint_Arch#Towards_the_preprint |our manuscript on 'Mitochondrial respiratory states and rates']] will follow soon.
::::* Will have a look.


* 2018-02-09 [[Lerfall J]]
:::: Kind regards,
::::* Off course! I can prepare a letter and forward this message to actual editors whom I know.  
:::: Erich
:::: Chair COST Action CA15203 MitoEAGLE
:::: [email protected] | www.mitoeagle.org


* 2018-02-09 [[Pardo Andreu GL]]
::::* Sure Erich. I will send it to a couple of editors. I will keep you informed.


* 2018-02-09 [[Saada A]]
== 2019-02-12 Circular to coauthors ==
::::* OK- I sent the letter to an editor of JIMD


* 2018-02-09 [[Valentine JM]]
:::: Dear coauthors,  
::::* The manuscript looks fantastic and I am very excited about it. Just a couple of comments. In the section on standardization. It is well outlined how proper standardization should be conducted; however in the manuscript we do not say, which method of standardization to use. For instance, flux can be normalized to wet weight or dry weight of the tissue (for permeabilized fibers) but we do not say which to use and the flux per mass values are very different depending on which you use. There is a lot more variability in weight wet measurements due to how much drying researcher does. Also, most scales are not accurate enough for measuring 1-2mg pieces of tissue and weighing the sample three times can give much more consistent values. If measurements are off by just one or even less than one mg when weighing a 1mg piece of muscle, then values can have double or half the respiration rates when normalizing to mass. Also, I recommend in the paper suggesting all raw data should be published in a supplemental table. This way anyone can access and compare values. Also, while the limitations of the normalizing factors are discussed in detail, we should specify which marker of mitochondrial content (CS activity mtDNA copy number) to use for normalizing. It may be important to explain that when phosphorylation is not limiting oxygen consumption such as in mouse permeabilized muscle fibers the addition of uncouplers does not increase oxygen flux; therefore, when generating flux control ratios using CI+CII_E to normalize to becomes confusing because CI+CII_P will also equal 1.
::::: As far as journals go, I think that diabetes would be a good journal to submit to if cell metabolism does not work out. Although it is limited to this one metabolic disorder nearly every researcher studying mitochondrial physiology have published in this journal.
::::: Another possible journal is EMBO as the word mitochondria turns up over 1500 articles and is a well read journal.
::::: ''[[Gnaiger E]]'': Thank you for your valuable comments. I agree with you, that recommendations on wet weight versus dry weight should be given. In fact, a MitoEAGLE Task Group is working on this to provide a comparative experimental basis for evaluation and a corresponding recommendation. This will be summarized in a separate MitoEAGLE position paper. Similarly, a recommendation on the ‘best’ mt-marker would be helpful, if such a best marker does exist. The present MS may contribute to make us more aware on the importance of paying critical attention to mt-markers. A insufficiently substantiated recommendation, however, would not help and weaken the impact of our manuscript.
::::: Ps: We are working on nomenclature of the pathway states. I regret to have introduced the CI+II nomenclature (but CI+CII is different), hence we replaced it with a less difficult terminology:
::::::* Lemieux H, Blier PU, Gnaiger E (2017) Remodeling pathway control of mitochondrial respiratory capacity by temperature in mouse heart: electron flow through the Q-junction in permeabilized fibers. Sci Rep 7:2840, DOI:10.1038/s41598-017-02789-8. - http://www.bioblast.at/index.php/Lemieux_2017_Sci_Rep
::::: [[Valentine JM]]: I agree and I am excited to contribute to this critical work in any way possible. Please let me know what I can do!!! Thank you for the reference paper. 


* 2018-02-08 [[Ahn B]]
:::: The MitoEAGLE manuscript on ‘Mitochondrial respiratory states and rates’ is now published in MitoFit Preprint Archives as a preprint citable with DOI number with 530 coauthors. The next step will be journal submission:
::::* I am happy to send a letter to editors. I came up with four editors from their Cell Metab website. They are Martin Brand, Michael Murphy, Nils-Goran Larsson, and Varnsi Mootha. I wanted to see if you suggest anyone else who I might include in the email as this will have an impact on our paper. I am happy with your template and will send it as is. I would also like to confirm that you want me to use the email address of [email protected] instead of individual emails of relevant editors.
:::: » http://wiki.oroboros.at/index.php/MitoFit_Preprint_Arch
* 2018-02-08 [[Battino M]]
::::* I'll do it with pleasure


* 2018-02-08 [[Casado Pinna M]]
:::: Why a new preprint server MitoFit Preprints? – On 2018-12-12 the MitoEAGLE manuscript was submitted to the preprint server www.biorxiv.org/. We are amazed that our manuscript was not accepted:
::::* Of course that I will send the letter to the known editors. I would appreciate if you would confirm if the idea is to send to Cell Metabolism or any journal that you know that includes studies of mitochondria such as Sci report, Hepatology, BBA, etc.
:::: » http://www.mitoeagle.org/index.php/Talk:MitoEAGLE_preprint_States_and_rates#BIORXIV
:::: Instead of starting a debate with bioRxiv we started MitoFit Preprints (originally MitoFit Preprint Archives) - the Open Access preprint server for mitochondrial physiology


* 2018-02-08 [[Genova ML]]
:::: The first DOI number was allocated to our MitoEAGLE manuscript.
::::* As you requested, I will think of possible Journal Editors (e.g. I am familiar with U. Brandt-BBA bioenergetis, but I suppose that you already asked him; if not, please let me know). Meanwhile, I wonder if you would like to consider also the possibility of submitting the same inquiry to the "Scientific Committee of the World Mitochondria Society", whose annual conference will be held as usual in Berlin (next date: October 2018 - https://www.targeting-mitochondria.com/)


* 2018-02-08 [[Labieniec-Watala M]]
:::: Your opinion means a lot to us. Therefore we would like to ask you:
::::* I have just looked at the preprint very quickly and I see many changes 😊 Wow! Very, very good job! During next days I will be reading it carefully. Now I am thinking about the journal where this review could be sent. So, in my opinion, this manuscript is excellent and you may consider to send it i.e. here ? :) ... Nature Methods, IF >25; of course earlier writing to editor
::::# Are you familiar with the concepts of preprints? '''Y / N'''
::::# Will you consider to submit a manuscript to MitoFit Preprints for publication as a preprint? '''Y / N'''
::::# Which alternative preprint server do you prefer? ___________
:::: The results of this questionnaire will be summarized anonymously on our website (beginning of March).


* 2018-02-08 [[Leeuwenburgh C]]
:::: We thank you for answering these questions in advance and are looking forward to your feedback. In particular, do you have further suggestions for our first journal choice for submission of our manuscript (Cell Metabolism)?
::::* Will do and send to other editors. I am the editor of experimental gerontology. Have you considered to publish this in a methods journal?


* 2018-02-08 [[Muntane J]]
:::: In the spirit of the bottom-up approach of MitoEAGLE, this is an invitation to join the editorial team (Scientific Advisory Board) of MitoFit Preprints.
::::* Thank you very much, I will send the input of the editors.


* 2018-02-08 [[Procaccio V]]
:::: Best regards,
::::* Great initiative. I will send the letter to the editors I know and will come back to you. Again thanks again for your efforts
:::: Erich Gnaiger
:::: Chair COST Action CA15203 MitoEAGLE
:::: [email protected] | www.mitoeagle.org


* 2018-02-08 [[Tomar D]]
::::* Many thanks for the information. I will disseminate the information.
::::: '''sent to ''': [email protected]


* 2018-02-08 [[Tronstad KJ]]
::::* '''2019-02-12: MitoEAGLE Task Group on 'Mitochondrial resipratory states and rates''''
::::* I know Keshav K Singh, Editor-in-chief of “Mitochondrion”, but I guess he might have been contacted  already?
[[File:Doi 10.26124 mitofit 190001.PNG|left|1000px|MitoEAGLE: States and rates - the preprint is citable with DOI number and getting ready for journal submission|thumb|link=http://www.mitoeagle.org/index.php/Gnaiger_2019_MitoFit_Preprint_Arch]]


* 2018-02-08 [[Ventura N]]
[[Image:BB-Bioblast.jpg|left|30px|link=Bioblast:About|Bioblast wiki]]
::::* Id be happy to forward the letter to Editors


* 2018-02-08 [[Wei YH]]
== Popular Bioblast page ==
::::* Thank you very much for your great effort in revising the manuscript and for sending me the revised version of this article that we have co-authored last year! It has been greatly improved!
::: [[Gnaiger 2019 MitoFit Preprints]] has been accessed more than
 
::::* 50,000 times (2019-12-11)
* 2018-02-08 [[Zullo S]]
::::* 35,000 times (2019-07-22)
::::* Yes, thanks for this and the preprint earlier. I will try to get it done by early next week.
 
 
* MitoEAGLE preprint 2018-02-08 Version 22

Latest revision as of 23:44, 25 January 2021

Nature Metabolism: NATMETAB-A19071509A Out to Review

Dear Prof Gnaiger,
Thank you for submitting your manuscript "Mitochondrial respiratory states and rates" to Nature Metabolism. I am pleased to tell you that we are sending your paper out for formal peer review.
If you have not done so already, please alert us to any related manuscripts from your group that are under consideration or in press at other journals, or are being written up for submission to other journals (see www.nature.com/authors/policies/duplicate.html for details).
We are trying to improve the quality of methods and statistics reporting in our papers. To that end, we are asking all life sciences authors to complete two items: an editorial policy checklist that verifies compliance with all required editorial policies and a reporting summary that collects information on experimental design and reagents.
Reporting summary: https://www.nature.com/documents/nr-reporting-summary.pdf
Editorial policy checklist: https://www.nature.com/documents/nr-editorial-policy-checklist.pdf
Please complete the relevant forms and return them within 48 hours. Please note that these forms are dynamic ‘smart pdfs’ and must therefore be downloaded and completed in Adobe Reader. We will then flatten them for ease of use by the reviewers. If you would like to reference the guidance text as you complete the template, please access these flattened versions at www.nature.com/authors/policies/availability.html
All points on the policy checklist must be addressed; if needed, please send me a new version of the manuscript with your completed checklist.
Finally, we would like to inform you that on a case by case basis we coordinate a brief consultation between referees and editors after all referee reports have been received. This is to improve the peer review process and the feedback provided to authors. Referees are given the opportunity to make comments on their peers’ concerns and update their reports to comment on issues raised by the other reviewers. If we feel it would be helpful, we will engage reviewers in this additional consultation with the goal of providing you with the most valuable feedback possible.
We will be in touch again as soon as we have received comments from our referees. In the meantime - the status of your manuscript can be followed in the manuscript tracking system.
Best regards,
Dr. Christoph Schmitt
Chief Editor
Nature Metabolism


Version 5


Version 5 for discussion

MitoFit pdf

Mitochondrial respiratory states and rates



Version 5 (v5) 2019-07-12 File:Gnaiger 2019 MitoFit Preprint Arch doi 10.26124 mitofit 190001.v5(in prep).pdf

Version 5 (v5) 2019-06-24 File:Gnaiger 2019 MitoFit Preprint Arch doi 10.26124 mitofit 190001.v5(in prep).pdf

Relevant changes
2019-07-24 Updates according to feedback from Gonzalez-Franquesa A and Fig. 1 edited by Bravo RF.
2019-07-12 Erich Gnaiger: A comment on 'Complex V' is added to Table 8:
Respiratory ET Complexes are redox proton pumps; Figure 2B; ATP synthase is not a redox proton pump of the ETS, hence the term Complex V should not be used
2019-06-24 Erich Gnaiger
1. ce: The term "Intact cells" has been replaced by "Living cells".
Rationale: see Table 5.
2. "Extra-mitochondrial" has been changed to "Extramitochondrial".
Compare: extracellular.
3. ""Excess E-P capacity has been changed to "ET-excess capacity, E-P".
Rationale: E-P is the excess capacity of E over P, but not excess over E-P.
4. The symbol "pmf" for protonmotive force has be replaced by pmF.
Rationale: (1) Italics are used for symbols of physicochemical quantities. (2) F but not f is the IUPAC symbol for force.
Added reference
  1. Ling C, Rönn T (2019) Epigenetics in human obesity and type 2 diabetes. Cell Metab 29:1028-44. https://doi.org/10.1016/j.cmet.2019.03.009. - »Bioblast link«
Coauthors: Version 4: 542; present: 611


ICJMD: Defining the role of authors and contributors

"Some large multi-author groups designate authorship by a group name, with or without the names of individuals. When submitting a manuscript authored by a group, the corresponding author should specify the group name if one exists, and clearly identify the group members who can take credit and responsibility for the work as authors. The byline of the article identifies who is directly responsible for the manuscript, and MEDLINE lists as authors whichever names appear on the byline. If the byline includes a group name, MEDLINE will list the names of individual group members who are authors or who are collaborators, sometimes called non-author contributors, if there is a note associated with the byline clearly stating that the individual names are elsewhere in the paper and whether those names are authors or collaborators." - Downloaded from www.icmje.org 2019-01-04


Comments

  • At the beginning of page 7 (In Box1), it is mentioned the crosstalk between ER and mitochondria. I think it should be included that this interaction plays an important role also in lipid transport and biosynthesis. The second comment regards the mechanisms of respiratory uncoupling and in particular the acoupled respiration described in Fig 3, page 14 and table 2. The acoupled respiration is described as the respiration occurring in “non-compartmental mitochondrial fragments”. May be this concept could be explain further, since I think that acoupled respiration can refer to just fragments of the inner mitochondrial membrane but also mitoplasts (obtained by mitochondria swelling in hypotonic buffer). So, acoupled respiration could refer to cases in which the integrity of either only the outer membrane or both inner and outer membrane is compromised. ~ Fontanesi F
  • I am happy to confirm that the pre-print has no flaws that I could see. It is truly an excellent work, for sure a manuscript of reference. ~ Teodoro J
  • I have been following the MitoEAGLE preprint on mitochondrial respiration, as well as the different comments. First of all, I am really interested in this topic, since as a student I already had troubles comparing different papers with different respiratory states, and this is a great opportunity to finally harmonize all the mitochondrial respiration experiments and publications. Pablo invited me to re-read it and make comments to contribute to the final final version. This would be a great honor, since this will be a reference paper in the future for experimental design and data reporting. .. I think it is a really elegant publication, with a lot of detail, but this is needed for the mitochondrial community to settle bases of nomenclature and harmonization. ~ Gonzalez-Franquesa A
  • Finally, I took the time to read the “Mitochondria States and Rates” preprint during the flight back home, I have one small comment: at the bottom of page 14, below table I, I get a bit confused all the way in this paragraph, but mostly by the part starting as “Defined coupling states are induced by…” (4 lines from the bottom). Somehow the points 1-4 that follow seem to refer to the states described in Table 1 above. If so, it may be clearer to arrange these points in the same order: seems that uncoupling (point 4) should go before inhibition of phosphorylation pathways (point 3) – I hope I’m not wrong for this? More generally, it might be useful for less advanced reader to relate the different parts of this paragraph to the states described in table I, following the same order given in the table: LEAK, OXPHOS, ET, ROX. As it is this paragraph starts with OXPHOS, then ET, then LEAK, with point 3 in the final description apparently being ROX. ~ Joseph V
Gnaiger E: Many thanks for your positive feedback. Your suggestions for the MitoEAGLE white paper are very helpful. See the file (in prep for Version 5) for discussion: See pp. 14-15 for the re-arrangements. I hope that the confusion is now taken away – let me know.
  • Nevertheless below some suggestions and remarks from my side, maybe you can use them for a revision. And of course I would be glad to see my favorite proteins mentioned (CK, NDPK, recent reviews attached). ~ Schlattner U
  • Please find (attached) my comments. I am glad to be part of this endeavour, which necessity is becoming increasingly clear every years! ~ Munro D
  • Fantastic initiative with the new mitochondrial physiology preprint server! ~ Donnelly C
  • It is quite surprising that the final manuscript was not accepted in BioRvix. I completely agree with MitoFit Preprints. ~ Singh BK
  • It will be a pleasure to join the MitoEagle task group publication. ~ Laranjinha J
  • I have a small remark : the concept of multiple authors signature started to be contested... By all ETHICS commities everywhere in Europa at least since it overpassed the usual rules... And also altered the signification of the authors impact factor. The regulation will be to form a consortium that is the true entity that will sign the collective work. That is teh best for teh COST since all members are easily identifiables. Overall conmment: This paper has been stanfding to long.... on teh bench! Petit PX
  • I just found a minor typo. If you look at the “S” references, they are out of alphabetical order. ~ Sparagna GC
  • Please find attached manuscript with comments (I have made 5 in total). Feel free to incorporate (or ignore) as you see fit! ~ McKenzie M
  • Gnaiger E: To address your comment “Interesting that you state saturating O2, as this is only at the start of an experiment? (but is accounted for in the oxygraph calibration with dithionite, so that measured respiration rates are relative to saturating O2?).”, I extended Section 2.1.2: “Kinetically-saturated conditions are evaluated by substrate kinetics to obtain the maximum reaction velocity or maximum pathway flux, in contrast to solubility-saturated conditions.”
We are in direct contact with Kyle Hoehn to obtain and test their uncouplers.
To summarize your comment “So would it be optimal in publications to not only state final flux rates/unit sample (e.g per mg) but also the raw flux rates (per mL) and the mg of sample used?”, I extended Box 3:Box 3: Recommendations for studies with mitochondrial preparations
● Normalization of respiratory rates should be provided as far as possible:
A. Sample normalization
1. Object-specific biophysical normalization: on a per organism or per cell basis as O2 flow; this may not be possible when dealing with coenocytic organisms, e.g., filamentous fungi, or tissues without cross-walls separating individual cells, e.g., muscle fibers.
2. Size-specific cellular normalization: per g protein; per organism-, cell- or tissue-mass as mass-specific O2 flux; per cell volume as cell volume-specific flux.
3. Mitochondrial normalization: per mitochondrial marker as mt-specific flux.
B. Chamber normalization
1. Chamber volume-specific flux, JV [pmol∙s-1∙mL-1], is reported for quality control in relation to instrumental sensitivity and limit of detection of volume-specific flux.
2. Sample concentration in the instrumental chamber is reported as number concentration, mass concentration, or mitochondrial concentration; this is a component of the measuring conditions.
With information on cell size and the use of multiple normalizations, maximum potential information is available (Renner et al. 2003; Wagner et al. 2011; Gnaiger 2014). Reporting flow in a respiratory chamber [nmol∙s-1] is discouraged, since it restricts the analysis to intra-experimental comparison of relative (qualitative) differences.
  • I am happy to see that we are one step closer to the final publication of the MitoEAGLE manuscript in a journal. ~ Komlodi T
  • It is a great step towards the publication of the manuscript and congratulations for creating your own tool to circumvent decisions that can not be easily understood. ~ Thierry A
  • Excellent article and one of its kind too. Please let me how can i help to get it published in a high impact j. Look forward to work in your team. ~ Sharma P
  • It's great to see the preprint. The preprint server in the area of mitochondrial physiology is a great idea and definitely will be a success. ~ Tomar D
  • First and foremost I would like to express my deepest gratitude and would like to thank you for giving us your time to review our manuscript and be part of us as the co-author. It is a great honour to get you in touch and reply promptly. .. I would like to also thank you for giving me the opportunity to be part of the MitoEAGLE as one of the co-authors and I am happy to be listed in the next version of the preprint. ~ Hassan H
  • However - just a note about pre-prints. A significant portion of scientists that I collaborate with feel uncomfortable submitting manuscript on a pre-print server. Is this something that could be addressed maybe in an article regarding the benefits and nuances of pre-print server submission. ~ Towheed A
Journal submission comments
  • Cell Metabolism seems like a good first choice. ~ Williams C
  • Cell Metabolism, I think this is a good choice. ~ Rossiter HB
  • Cell Metabolism seems highly appropriate. ~ Newsom SA
  • No preference. Just go ahead. ~ Zaugg M
  • I concur with the choice of cell metabolism. ~ Pulinilkunnil T
  • I think cell metabolism would be great, but I doubt whether it is realistic. Possibly Molecular Metabolism (very rapid, good reputation, european), Cell and Molecular Life Sciences (many reviews) or BBA- bioenergetics could be alternatives. ~ Keijer J
  • Alternatives if Cell Met is not accepting: Nature metabolism or Acta physiologica. ~ Amati F
  • And Cell met is a good 1st choice for this publication. ~ Zanou N
  • The question is why did Biorxiv reject the manuscript? Before submitting to a prestigious journal like Cell Metabolism all the doubts Biorxiv had should be ruled out. ~ Methner A
  • And I think that Cell Metabolism is a good first journal choice for submission of our manuscript. ~ Breton S
  • Cell Metabolism is a good option as a first submission. ~ Bouitbir J
  • Cell metabolism is a good fit for the manuscript. ~ Adiele RC
  • The choice of journal is excellent, although it might be a long shot. ~ Oliveira MT
  • I guess that also TIBs or Current Biology could be considered. ~ Calabria E
  • I am in agreement that the first journal will be Cell Metabolism. ~ Victor VM
  • Cell metabolism is an excellent choice. If they are interested that would be wonderfull. Physiological Reviews could be an alternative, in case Cell metabolism declines the manuscript. ~ Thierry A
  • I would suggest to try the submission in Cell Metabolism. ~ Doerrier C
  • Regarding the future submission of our paper, if there is already a pre-acceptance of the Editor of Cell Metabolism, I believe we should submit there. There are not many journals willing to publish a paper with so many authors, and the reviewing process will not be easy, in my opinion. ~ Crisostomo L
  • I think cell metabolism is a good target to submit our article. ~ Salin K
  • I would format accurately as a resource manuscript for Cell Metabolism. ~ Lavery GG
  • The manuscript is still extremely long. In my modest opinion too long compared to the editorial format limits of many journals. If the manuscript cannot be substantially shortened to the essentials (in my opinion preferable) one strategy is to try to find a journal without such limits. ~ Spinazzi M
  • I am happy with Cell Metabolism to start the submission process of this preprint. ~ Moisoi N

2019-07-22 Circular to coauthors

Re: MitoEAGLE preprint on ‘Mitochondrial respiratory states and rates’
Dear coauthors,
The recent MiP/MitoEAGLE Training School in Coimbra provided another excellent opportunity to present the concept of our ‘States and rates’ white paper, to discuss it with several students and scientists who joined as additional coauthors, and to take a decision on journal submission.
1. Preprint version 5 (in prep) is now available for your evaluation before proceeding with journal submission. At this stage, the MitoFit Preprint version 5 (in prep) has not yet a DOI, to allow final changes to be made according to the immediate feedback received upon this circular. The latest changes are listed on the website, minor changes and improvements are included in the manuscript:
» www.mitofit.org/index.php/Talk:Gnaiger_2019_MitoFit_Preprint_Arch
2. Please finally check your personal page for any corrections to be made in your initials and affiliations.
3. Feel free to invite additional colleagues to evaluate our white paper and join as coauthors.
4. We have announced the plan for journal submission for quite some time, but the number of coauthors increased to 612 and many discussions lead to further improvement of the manuscript. Our first goal for submission has been ‘Cell Metabolism’. Since then, the new journal ‘Nature Metabolism’ was launched. Feedback from several coauthors, and the interest of the editor of ‘Nature Metabolism’ in our white paper, has led to a change in the strategy, to submit primarily to the European journal ‘Nature Metabolism’, since the COST Action MitoEAGLE is a European project-with worldwide participation.
With many thanks for your contributions and for supporting the MitoEAGLE project,
Erich
Erich Gnaiger, Ph.D.
Chair COST Action MitoEAGLE
[email protected] | www.mitoeagle.org


2019-03-12 Circular to coauthors

Re: MitoFit_Preprint_Archives
Dear coauthors,
We thank you for the feedback received to our previous circular. Here is the summary of 176 answers to the three questions on preprints, which encourages us to proceed with MitoFit Preprint Archives:
» Summary on preprint questionnaire
The Scientific Advisory Board has expanded, and we thank all MitoEAGLE members who have joined the International Board. Again we extend our invitation to join the editorial team. In particular, we would like to establish a Member Advisory Board including scientific organizations and journals which support the concept of MitoFit Preprints. If you are involved in such an organization, please let us know if joining the 'Member Advisory Board' might be an option for your organization.
Information on next steps for our manuscript on 'Mitochondrial respiratory states and rates' will follow soon.
Kind regards,
Erich
Chair COST Action CA15203 MitoEAGLE
[email protected] | www.mitoeagle.org


2019-02-12 Circular to coauthors

Dear coauthors,
The MitoEAGLE manuscript on ‘Mitochondrial respiratory states and rates’ is now published in MitoFit Preprint Archives as a preprint citable with DOI number with 530 coauthors. The next step will be journal submission:
» http://wiki.oroboros.at/index.php/MitoFit_Preprint_Arch
Why a new preprint server MitoFit Preprints? – On 2018-12-12 the MitoEAGLE manuscript was submitted to the preprint server www.biorxiv.org/. We are amazed that our manuscript was not accepted:
» http://www.mitoeagle.org/index.php/Talk:MitoEAGLE_preprint_States_and_rates#BIORXIV
Instead of starting a debate with bioRxiv we started MitoFit Preprints (originally MitoFit Preprint Archives) - the Open Access preprint server for mitochondrial physiology
The first DOI number was allocated to our MitoEAGLE manuscript.
Your opinion means a lot to us. Therefore we would like to ask you:
  1. Are you familiar with the concepts of preprints? Y / N
  2. Will you consider to submit a manuscript to MitoFit Preprints for publication as a preprint? Y / N
  3. Which alternative preprint server do you prefer? ___________
The results of this questionnaire will be summarized anonymously on our website (beginning of March).
We thank you for answering these questions in advance and are looking forward to your feedback. In particular, do you have further suggestions for our first journal choice for submission of our manuscript (Cell Metabolism)?
In the spirit of the bottom-up approach of MitoEAGLE, this is an invitation to join the editorial team (Scientific Advisory Board) of MitoFit Preprints.
Best regards,
Erich Gnaiger
Chair COST Action CA15203 MitoEAGLE
[email protected] | www.mitoeagle.org


  • 2019-02-12: MitoEAGLE Task Group on 'Mitochondrial resipratory states and rates'
MitoEAGLE: States and rates - the preprint is citable with DOI number and getting ready for journal submission
Bioblast wiki

Popular Bioblast page

Gnaiger 2019 MitoFit Preprints has been accessed more than
  • 50,000 times (2019-12-11)
  • 35,000 times (2019-07-22)
Cookies help us deliver our services. By using our services, you agree to our use of cookies.